Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis
2006; Lippincott Williams & Wilkins; Volume: 37; Issue: 9 Linguagem: Inglês
10.1161/01.str.0000237210.15986.d6
ISSN1524-4628
AutoresGeoffrey A. Donnan, Stephen M. Davis, Peter D. Schellinger, Werner Hacke,
Tópico(s)Intracerebral and Subarachnoid Hemorrhage Research
ResumoHomeStrokeVol. 37, No. 9Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBIntra-Arterial Thrombolysis Is the Treatment of Choice for Basilar ThrombosisPro Geoffrey A. Donnan, MD, FRACP, Stephen M. Davis, MD, FRACP, Peter D. Schellinger, MD, PhD and Werner Hacke, MD, PhD Geoffrey A. DonnanGeoffrey A. Donnan From the Departments of Neurology, University of Erlangen (P.D.S.) and University of Heidelberg (W.H.), Germany. , Stephen M. DavisStephen M. Davis From the Departments of Neurology, University of Erlangen (P.D.S.) and University of Heidelberg (W.H.), Germany. , Peter D. SchellingerPeter D. Schellinger From the Departments of Neurology, University of Erlangen (P.D.S.) and University of Heidelberg (W.H.), Germany. and Werner HackeWerner Hacke From the Departments of Neurology, University of Erlangen (P.D.S.) and University of Heidelberg (W.H.), Germany. Originally published3 Aug 2006https://doi.org/10.1161/01.STR.0000237210.15986.d6Stroke. 2006;37:2436–2437Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: August 3, 2006: Previous Version 1 Parachutes to prevent death and disability from gravitational challenge.The basis for parachute use is purely observational,Apparent efficacy could be explained by a healthy cohort effect,Individuals who insist that all interventions need to be validated by a RCT need to come down to earth with a bump.1Basilar artery thrombosis (BAT) is a rare but most severe subtype of ischemic stroke often presenting with progressive or hyperacute brain stem symptoms, tetraplegia and loss of consciousness ranging from somnolence to frank coma. It is associated with a mortality between 50% and 90% in patients treated conventionally (antiplatelets or heparin) or not at all.2,3 If survived, the consequence frequently is a locked-in syndrome, the most gruelsome outcome thinkable. Different patterns include caudal vertebrobasilar, mid-basilar and top-of-the-basilar thrombosis, the former mostly being of atherothrombotic and the latter of embolic origin.4 Multiple case series mostly addressing intra-arterial (IA) and less frequently intravenous5 thrombolytic therapy for BAT have been published in the last 20 years, the first report by Zeumer et al dating back to 1982.6,7 Most studies suffered from small numbers: <10 patients with only a few in the range of 40 to 50 patients.2,8,9 All had an open, retrospective or partly prospective design with differing treatment regimens, mostly IA thrombolytic drugs formally rendering level III evidence at best.Whereas some studies only used presence or absence of recanalization induced by a thrombolytic as a surrogate outcome, in all but 1 series it was shown that overall survival and an independent outcome was associated with successful partial or complete recanalization of the occluded basilar artery (BAO).2,8,9 Recanalization rates ranged from 40% to 100%, on average &50% to 60% in line with the results from the Prolyse in Acute Cerebral Thromboembolism II (PROACT II) trial.10 Survival in patients without recanalization ranged from 0% to 20% as opposed to 40% to 80% in those with recanalization. A recent meta-analysis by Lindsberg analyzed systematically published case series of ≥10 patients reporting the outcome of BAO after IA or IV thrombolysis within 12 hours.11 In 420 BAO patients treated with IV thrombolysis (n=76) and IA thrombolysis (n=344), death or dependency were equally common: 78% (59 of 76) and 76% (260 of 344), respectively (P=0.82). Recanalization was achieved more frequently with IA thrombolysis (225 of 344; 65%) than with IV thrombolysis (40 of 76; 53%; P=0.05), but survival rates after IV thrombolysis (38 of 76; 50%) and IA thrombolysis (154 of 344; 45%) were similar (P=0.48). A total of 24% of patients treated with IA thrombolysis and 22% treated with IV thrombolysis reached good outcomes (P=0.82). Without at least partial recanalization, the likelihood of a good outcome was close to zero (2% versus 38%).An Australian group ventured to perform a randomized trial (Australasian Urokinase Stroke Study)12 after a pilot trial (Australasian Urokinase Stroke Trial [AUST]) published in 1997.13 The pilot study included 15 patients within 31 hours (mean 18 hours) in an uncontrolled observational design. Eleven of 15 patients recanalized, 10 of these survived (only 1/4 nonrecanalizers). The AUS study was designed as an open-label, multicenter, randomized controlled trial with a blinded end point assessment and launched in 1996.12 Inclusion criteria were an acute posterior circulation stroke syndrome <24 hours time from symptom onset, age 18 to 85, and no hemorrhage on CT. Patients underwent digital subtraction angiography and, if a lysable lesion was identified, were randomized to either heparin (unfractionated, partial thromboplastin time [PTT] 60 to 80 s, 5000 IU bolus) or heparin plus IA urokinase (increments of 100 000 IU up to a maximum of 1 000 000 IU) followed by warfarin (international normalized ratio, 1.5 to 2.5) for 6 months. Clinical outcomes (modified Rankin Scale, National Institutes of Health Stroke Scale, Barthel Index) were independently assessed by a nurse or neurologist blinded for treatment. The study was terminated because of low recruitment (20 patients screened, 16 randomized). There were only 4 deaths in each group, 7/8 in the placebo group were disabled or dead, only 4 in the treatment group (ie, all survivors had an independent outcome). The early termination is disappointing because the total sample size would have been 65 patients (absolute effect size of 35%, 2-sided α, power 0.8) to answer this question once and for all with IA thrombolysis for vertebrobasilar stroke becoming a level A recommendation.Taking into account recent recommendations14 a new randomized study could screen with CT angiography, randomize 2 (active IA):1 (placebo), and have a consistent protocol regarding the therapeutic strategies such as concomitant treatment with abciximab, use of devices and other interventions.We believe such a study would be desirable but it will never happen. The condition itself is rare, and we doubt that logistical problems can be overcome, and investigators at the expert centers with the largest experience will hesitate to randomize their patients. On the other hand, do we really need a new trial? Recanalization and reperfusion whether in anterior or posterior territory stroke is the strongest predictor if not a conditio sine qua non for survival and independence. The currently available data albeit not level I evidence provide more than enough information in favor of IA thrombolysis (maybe also IV thrombolysis) for BAT. In fact, in our opinion it is not the worst level of evidence if one can show that a drug designed to lyse clots can do exactly that in a considerable percentage of patients experiencing stroke attributable to an occluded vessel, and that those patients, whose vessels are reperfused have a far better outcome. In addition, upcoming studies using devices and add-on medications as well as PTA and stenting (eg, the Interventional Management of Stroke studies) likely will strengthen our point.15Therefore, although we advocate randomized studies to answer several questions in acute and secondary prophylactic treatment of stroke we find it ethically unacceptable to randomize a patient to placebo versus conventional treatment thereby precluding him the chance of &50% for surviving an otherwise almost always deadly stroke and a &35% chance for being an independent survivor. We doubt that critics of IA thrombolysis for BAT would consent to inclusion in such a placebo-controlled study for themselves or their next of kin, like we doubt they would enter the above-mentioned parachute trial. At a certain point, patients with an infrequent disease with such a grim prognosis should be treated despite lack of level I evidence data. "Stop trying to control everything and just let go. Let go!"16FootnotesCorrespondence to Peter D. Schellinger, MD, PhD, Neurologische Klinik, Universitätsklinikum Erlangen, Schwabachanlage 6, D-91054 Erlangen, Germany. E-mail [email protected]References1 Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomized controlled trials. BMJ. 2003; 327: 1459–1461.CrossrefMedlineGoogle Scholar2 Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo G. Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988; 19: 1216–1222.CrossrefMedlineGoogle Scholar3 Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005; 76: 1238–1241.CrossrefMedlineGoogle Scholar4 Brandt T, Steinke W, Thie A, Pessin MS, Caplan LR. Posterior cerebral artery territory infarcts: Clinical features, infarct topography, causes and outcome. Multicenter results and a review of the literature. Cerebrovasc Dis. 2000; 10: 170–182.CrossrefMedlineGoogle Scholar5 Lindsberg PJ, Soinne L, Tatlisumak T, Roine RO, Kallela M, Happola O, Kaste M. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA. 2004; 292: 1862–1866.CrossrefMedlineGoogle Scholar6 Zeumer H, Hacke W, Kolmann HL, Poeck K. [Local fibrinolysis in basilar artery thrombosis (author's translation)]. Dtsch Med Wochenschr. 1982; 107: 728–731.CrossrefMedlineGoogle Scholar7 Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke-a review. Part II-intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med. 2001; 29: 1819–1825.CrossrefMedlineGoogle Scholar8 Brandt T, von Kummer R, Muller Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke. 1996; 27: 875–881.CrossrefMedlineGoogle Scholar9 Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturzenegger M, Schuknecht B, Mattle HP. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry. 2004; 75: 857–862.CrossrefMedlineGoogle Scholar10 Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999; 282: 2003–2011.CrossrefMedlineGoogle Scholar11 Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006; 37: 922–928.LinkGoogle Scholar12 Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005; 20: 12–17.CrossrefMedlineGoogle Scholar13 Mitchell PJ, Gerraty RP, Donnan GA, Fitt G, Tress BM, Thomson KR. Thrombolysis in the vertebrobasilar circulation - the Australian Urokinase Stroke Trial (AUST) pilot study. Cerebrovasc Dis. 1997; 7: 94–99.CrossrefGoogle Scholar14 Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003; 34: e109–137.LinkGoogle Scholar15 Major ongoing stroke trials. Stroke. 2006; 37: e18–e26.LinkGoogle Scholar16 Tyler (Brad Pitt), from the Fox movie "Fight Club"; 1999.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Hayes M, Kaestner V, Mailankody S and Prasad V (2018) Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes, CMAJ Open, 10.9778/cmajo.20170088, 6:1, (E31-E38), Online publication date: 1-Jan-2018., Online publication date: 15-Jan-2018. Harrigan M and Deveikis J (2018) Treatment of Acute Ischemic Stroke Handbook of Cerebrovascular Disease and Neurointerventional Technique, 10.1007/978-3-319-66779-9_8, (431-500), . Schellinger P, Schulte-Altedorneburg G and Hacke W (2015) Basilaristhrombose – Ischämie des hinteren Kreislaufs – Hirnstammsyndrome NeuroIntensiv, 10.1007/978-3-662-46500-4_28, (411-423), . Lindsberg P, Sairanen T and Mattle H (2014) Critical care of basilar artery occlusion Critical Care of the Stroke Patient, 10.1017/CBO9780511659096.020, (194-205) Harrigan M and Deveikis J (2013) Treatment of Acute Ischaemic Stroke Handbook of Cerebrovascular Disease and Neurointerventional Technique, 10.1007/978-1-61779-946-4_9, (343-398), . Schellinger P and Schulte-Altedorneburg G (2012) Basilaristhrombose – Ischämie des hinteren Kreislaufs – Hirnstammsyndrome NeuroIntensiv, 10.1007/978-3-642-16911-3_28, (391-403), . Schellinger P, Köhrmann M and Röther J (2012) Industriegeförderte TherapiestudienIndustry-funded therapy studies, Der Nervenarzt, 10.1007/s00115-012-3534-5, 83:10, (1260-1269), Online publication date: 1-Oct-2012. Pagola J, Ribo M, Alvarez-Sabin J, Rubiera M, Santamarina E, Maisterra O, Delgado-Mederos R, Ortega G, Quintana M and Molina C (2011) Thrombolysis in Anterior Versus Posterior Circulation Strokes: Timing of Recanalization, Ischemic Tolerance, and Other Differences, Journal of Neuroimaging, 10.1111/j.1552-6569.2009.00462.x, 21:2, (108-112), Online publication date: 1-Apr-2011. Chandra R, Law C, Yan B, Dowling R and Mitchell P (2011) Glasgow Coma Scale Does Not Predict Outcome Post-Intra-Arterial Treatment for Basilar Artery Thrombosis, American Journal of Neuroradiology, 10.3174/ajnr.A2325, 32:3, (576-580), Online publication date: 1-Mar-2011. Cohen J, Itshayek E, Moskovici S, Gomori J, Fraifeld S, Eichel R and Leker R (2011) State-of-the-art reperfusion strategies for acute ischemic stroke, Journal of Clinical Neuroscience, 10.1016/j.jocn.2010.10.008, 18:3, (319-323), Online publication date: 1-Mar-2011. Tanaka Y, Yoshimura S, Egashira Y, Yamada K, Enomoto Y and Iwama T (2011) Aggressive Endovascular Reperfusion Therapy for Acute Basilar Artery Occlusion, Japanese Journal of Neurosurgery, 10.7887/jcns.20.678, 20:9, (678-685), . Leker R, Grigoriadis S and Cohen J (2013) Endovascular reperfusion therapy for acute ischemic stroke: a meta-analysis, Neurological Research, 10.1179/174313209X382430, 32:8, (787-791), Online publication date: 1-Oct-2010. Alexandrov A (2010) Current and future recanalization strategies for acute ischemic stroke, Journal of Internal Medicine, 10.1111/j.1365-2796.2009.02206.x, 267:2, (209-219), Online publication date: 1-Feb-2010. Arenillas Lara J (2010) Trombosis aguda de la arteria basilar, Neurología, 10.1016/S0213-4853(10)70046-3, 25, (18-23), Online publication date: 1-Oct-2010. Bonatti G, Ferro F, Haglmüller T, Pernter P and Naibo L (2010) Basilar artery thrombosis: imaging and endovascular therapyOcclusione dell'arteria basilare: diagnostica per immagini e terapia endovascolare, La radiologia medica, 10.1007/s11547-010-0568-2, 115:8, (1219-1233), Online publication date: 1-Dec-2010. Nagel S, Schellinger P, Hartmann M, Juettler E, Huttner H, Ringleb P, Schwab S and Köhrmann M (2008) Therapy of Acute Basilar Artery Occlusion, Stroke, 40:1, (140-146), Online publication date: 1-Jan-2009. Köhrmann M and Schellinger P (2009) Acute Stroke Triage to Intravenous Thrombolysis and Other Therapies with Advanced CT or MR Imaging: Pro MR Imaging, Radiology, 10.1148/radiol.2513081074, 251:3, (627-633), Online publication date: 1-Jun-2009. Raphaeli G, Eichel R, Ben-Hur T, Leker R and Cohen J (2009) MULTIMODAL REPERFUSION THERAPY IN PATIENTS WITH ACUTE BASILAR ARTERY OCCLUSION, Neurosurgery, 10.1227/01.NEU.0000350862.35963.49, 65:3, (548-553), Online publication date: 1-Sep-2009. Harrigan M and Deveikis J (2009) Thrombolysis for Acute Ischemic Stroke Handbook of Cerebrovascular Disease and Neurointerventional Technique, 10.1007/978-1-60327-125-7_9, (301-346), . Humpich M, Byhahn C, Fowler R and Labiche L (2009) Stroke: acute stroke receiving facilities and management, Current Opinion in Critical Care, 10.1097/MCC.0b013e32832e4566, 15:4, (295-300), Online publication date: 1-Aug-2009. Pfefferkorn T, Mayer T, Opherk C, Peters N, Straube A, Pfister H, Holtmannspötter M, Müller-Schunk S, Wiesmann M and Dichgans M (2008) Staged Escalation Therapy in Acute Basilar Artery Occlusion, Stroke, 39:5, (1496-1500), Online publication date: 1-May-2008. Chong B, Demaerschalk B and Patel A (2008) Thrombolysis, angioplasty and stenting of acute basilar artery occlusion in an octogenarian, Radiology Case Reports, 10.2484/rcr.v3i2.157, 3:2, (157), . Schellinger P, Brandt T, Mayer T and Schulte-Altedorneburg G Basilaristhrombose — Ischämie des hinteren Kreislaufs — Hirnstammsyndrome NeuroIntensiv, 10.1007/978-3-540-68317-9_31, (403-415) Finelli P (2008) Neuroimaging in Acute Posterior Cerebral Artery Infarction, The Neurologist, 10.1097/NRL.0b013e3181627679, 14:3, (170-180), Online publication date: 1-May-2008. Iorio A, Moja L, Liberati A, Gensini G, Gusinu R and Conti A (2008) Selecting references that match constructs: the difficult job of citing the parachute hyperbole, Internal and Emergency Medicine, 10.1007/s11739-008-0149-8, 3:2, (151-154), Online publication date: 1-Jun-2008. Lindsberg P and Mattle H (2006) Response to Letter by Schulte-Altedorneburg et al, Stroke, 38:1, (10-11), Online publication date: 1-Jan-2007.Ciccone A, Valvassori L, Gasparotti R, Scomazzoni F, Ballabio E and Sterzi R (2007) Debunking 7 Myths That Hamper the Realization of Randomized Controlled Trials on Intra-Arterial Thrombolysis for Acute Ischemic Stroke, Stroke, 38:7, (2191-2195), Online publication date: 1-Jul-2007.Vatankhah B, Schlachetzki F and Audebert H (2007) Therapy of Basilar Artery Occlusion: Individual Protocols Needed, Stroke, 38:6, (e29-e29), Online publication date: 1-Jun-2007.Pagola J, Ribo M, Alvarez-Sabín J, Lange M, Rubiera M and Molina C (2007) Timing of Recanalization After Microbubble-Enhanced Intravenous Thrombolysis in Basilar Artery Occlusion, Stroke, 38:11, (2931-2934), Online publication date: 1-Nov-2007. Kumar S and Caplan L (2007) Why identification of stroke syndromes is still important, Current Opinion in Neurology, 10.1097/WCO.0b013e328013e964, 20:1, (78-82), Online publication date: 1-Feb-2007. September 2006Vol 37, Issue 9 Advertisement Article InformationMetrics https://doi.org/10.1161/01.STR.0000237210.15986.d6PMID: 16888252 Manuscript receivedMay 16, 2006Manuscript acceptedJune 12, 2006Originally publishedAugust 3, 2006 KeywordsthrombolysisPDF download Advertisement
Referência(s)